{"entity":{"id":"nct06824064","kind":"trial","name":"Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer","aka":[],"tldr":"A phase 2 trial of RBS2418 in colorectal cancer, run by Riboscience, LLC., now recruiting.","summary":"Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer is a phase 2 interventional study registered as NCT06824064 by Riboscience, LLC., with 150 participants planned, started 2025-01-17 and due to reach its primary completion in 2027-12. Interventions recorded: RBS2418 and Placebo.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06824064","url":"https://clinicaltrials.gov/study/NCT06824064"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06824064","phase":"2","setting":"A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study of RBS2418 Plus Best Supportive Care (BSC) in Subjects With Advanced, Metastatic, and Progressive Colorectal Cancer","sponsor":"Riboscience, LLC.","enrolled":150,"outcomes":[]},"route":"/trials/nct06824064/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}]}}